Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis

ConclusionMaintenance prolonged survival in CR and in VGPR/PR patients. The benefit in CR patients suggests the importance of continuing treatment in patients with chemo-sensitive disease.Trial registrationThe two source studies are registered at ClinicalTrials.gov: identification  numbers NCT01063179 and NCT00551928.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research